Showing results (331-340 of 377) with videos related to
Sort By:
Pageof 38
Journal of Neurosurgery|April 13, 2000
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidanceB P Bejjani, D Dormont, B Pidoux, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 20, 2019
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?M Bastard, E Sanchez-Padilla, A Hayrapetyan, et al.Neurology|June 15, 2007
Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?P Charles, A Camuzat, N Benammar, et al.Journal of Cellular Physiology|March 17, 2010
Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cellsAkiko Miki, Katsuaki Miki, Shinji Ueno, et al.The British Journal of Dermatology|May 20, 2003
Decreased expression of keratinocyte beta1 integrins in chronically sun-exposed skin in vivoS Bosset, M Bonnet-Duquennoy, P Barré, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 19, 2005
Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countriesM Bonnet, V Sizaire, Y Kebede, et al.AJNR. American Journal of Neuroradiology|June 1, 1997
Chronic thalamic stimulation with three-dimensional MR stereotactic guidanceD Dormont, P Cornu, B Pidoux, et al.Physiological Chemistry and Physics|January 1, 1982
Estimating meconium (fetal feces) concentration in human amniotic fluid by nuclear magnetic resonanceB Borcard, E Hiltbrand, P Magnin, et al.International Journal of Cosmetic Science|May 21, 2008
Expression and function of neurotrophins and their receptors in human melanocytesA Marconi, M C Panza, M Bonnet-Duquennoy, et al.Antimicrobial Agents and Chemotherapy|March 26, 2014
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatmentN B Bhatt, C Barau, A Amin, et al.Pageof 38